While CCNB1 and CHEK1 showed decreased eigenvector centrality in metastasis, CHEK1 plays a key role in the DNA damage response [32] and contributes to tumor progression and therapy resistance in PCa, particularly in metastatic castration-resistant prostate cancer (CRPC) [33]. This evidence concerns the gene CHEK1 and neoplasm.